IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Clinical trial NCT07686380 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686380
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-23
- Primary completion
- 2029-01-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.